Loading…
Attending this event?
Tuesday, June 18 • 3:15pm - 4:15pm
#268: Strategies to Make your Clinical Trials More Inclusive for Patients with Disabilities

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Workshop
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-24-600-L04-P; CME 1.00; RN 1.00

This workshop will assist attendees with ways to properly accommodate medically complex and/or rare disease patients through providing accessibility tools and solutions. Soft skills and “person first” language will be discussed.

Learning Objectives

Identify how to expand the definition of diversity; Describe how to have conversations with patients about disabilities; Explore solutions and recommendations for no/low-cost actions you can take to make your facility as accessible as possible for a variety of disabilities; Define resources for support and training for site staff.

Chair

Stacy Hurt, MBA, MHA

Speaker

Facilitator
Carlos Orantes, MBA

Facilitator
Cecile Gonzalez-Cerimele

Facilitator
Mindy Cameron


Speakers
avatar for Stacy Hurt, MBA, MHA

Stacy Hurt, MBA, MHA

Chief Patient Officer, Parexel International, United States
Stacy Hurt, MHA, MBA is an award-winning 25 year pharma executive who bridges the industry/consumer gap as a stage IV cancer survivor and 24/7 caregiver to her son with a rare disease. Her unique professional and personal experience position her as an esteemed patient advocate as... Read More →
MC

Mindy Cameron

Patient Advocate, Advocacyworks, United States
Mindy Cameron's evolution as a rare disease patient expert started over 20 years ago when her second son was diagnosed with Duchenne muscular dystrophy. Through her work with non-profit, research, and industry organizations, Mindy has become a recognized voice for patients living... Read More →
CG

Cecile Gonzalez-Cerimele

Executive Director Diversity and Inclusion in Clinical Trials, Eli Lilly and Company, United States
Leader with over 30 years in the pharmaceutical sector spanning discovery, New Product Planning, late-stage development, and COVID-19 Ab program. Current focus is on crafting strategies that bolster awareness, education, and availability of CTs for underrepresented groups worldwide... Read More →
avatar for Carlos Orantes

Carlos Orantes

Chief Executive Officer, Alcanza Clinical Research, United States

Tuesday June 18, 2024 3:15pm - 4:15pm PDT
Room 2 San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  05: Patient-Focused Drug Dev, Workshop